Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature

Table 1

Worldwide human papilloma virus coverages among female population aged 10–20 years, the cervical cancer incidence (by continent), and the health care systems (by countries).

Geographical region	HPV vaccine coverage	Cervical cancer incidence (cumulative risk 0–74) (%)
Africa	1.2% (0.6–2.0)	Eastern Africa	4.34
		Middle Africa	3.02
		Northern Africa	0.82
		Southern Africa	4.20
		Western Africa	3.47
Asia	1.2% (0.7–1.8)	Eastern Asia	1.09
		South-Eastern Asia	1.86
		South-Central Asia	1.41
		Western Asia	0.45
Europe	36.4% (30.3–42.9)	Central and Eastern Europe	1.58
		Western Europe	0.66
		Southern Europe	0.77
		Northern Europe	0.85
Latin America and Caribbean	22.1% (12.7–32.6)	Caribbean	1.54
		Central America	1.32
		South America	1.56
North America	53.4% (27.1–85.6)	North America	0.62
Oceania	41.1% (21.5–64.0)	Australia and New Zealand	0.55
		Melanesia	2.60
		Polynesia	1.16
		Micronesia	2.03

Data in parentheses are 95% confidence interval.